The landscape of dementia analysis has developed considerably with the arrival of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades in advance of indicators emerge. While these technological innovations characterize exceptional progress in being familiar with neurodegenerative disorders, ... https://vonz985xgq4.wikinewspaper.com/user